Research AppraisalRandomised Controlled Trial

Comparison between foam dressings impregnated with ionic silver and silver sulfadiazine cream 1% in treating deep burns.

Journal of wound careAlmeida, Juliano Baron, Coltro, Pedro Soler, Nunes, Altacilio Aparecido et al.2 May 2026DOI

Clinical Snapshot

50CEBM
Evidence: WeakRandomised Controlled Trial

PICO Framework

P — PopulationAdults aged 18-60 years with thermal burns affecting 10-30% body surface area with comparable percentage of deep dermal and full-thickness burns
I — InterventionFoam dressings impregnated with ionic silver (AgF)
C — Comparator1% silver sulfadiazine cream (SSD)
O — OutcomesPain control, discomfort, wound infection, need for grafting, ease of application, length of stay, treatment cost

Bottom Line

This small randomised trial (n=40) suggests ionic silver foam dressings may offer superior pain control and cost savings compared to silver sulfadiazine cream in deep burns. However, the study's validity is significantly limited by inadequate reporting of methodology, lack of statistical precision measures, and absence of blinding. While the 30.6% cost reduction is economically attractive, clinicians should interpret these preliminary findings cautiously. The comprehensive outcome assessment including patient comfort and economic factors is commendable, but larger, more rigorously reported trials are needed before changing established burn care protocols. The inability to blind participants and assessors to treatment allocation introduces substantial bias risk, particularly for subjective outcomes like pain and comfort.

Evidence: Weak

Key Findings

  • P Value: Not reported

  • Effect Size: Not quantified in abstract

  • Primary Outcome: More effective pain control with ionic silver foam dressings

  • Nnt Or Sensitivity: Not calculable from available data

  • Confidence Interval: Not reported

Clinical Application

Ionic silver foam dressings readily available but may require staff training for optimal application Both treatments available through PBS for burn management; cost-effectiveness data relevant for hospital formulary decisions and clinical guidelines Adult burn patients with 10-30% TBSA deep burns in specialised burn units

Abstract

OBJECTIVE: The aim of this trial was to evaluate the effectiveness of foam dressings impregnated with ionic silver (AgF) compared to the traditional treatment of 1% silver sulfadiazine cream (SSD) in deep burns (deep dermal and full-thickness burns) and assess the cost-effectiveness ratio between the two treatments. METHOD: This was a randomised clinical trial of patients who were divided into two equal-sized treatment groups: Group 1-SSD or Group 2 - AgF. Inclusion criteria were patients aged between 18-60 years with burns of thermal origin affecting 10-30% of the body surface area, and with a comparable percentage of deep burns. The following outcomes were analysed: pain; discomfort; wound infection; need for new grafting; ease of dressing application; length of stay; and cost of treatment. RESULTS: A total of 40 patients took part (20 in each group). Regarding patients' experience of pain, data analysis revealed more effective pain control in patients treated with AgF. Additionally, the AgF dressing was considered safer, more comfortable and presented an average lower cost of 30.6% compared to the SSD. CONCLUSION: The findings of this trial showed that, compared to the SSD, the AgF dressings were more effective in treating deep burns, to prepare them for skin graft surgery.

References

  1. 1.Almeida, J. B., Coltro, P. S., Nunes, A. A., & Farina, J. A. (2024). Comparison between foam dressings impregnated with ionic silver and silver sulfadiazine cream 1% in treating deep burns. Journal of Wound Care. https://doi.org/10.12968/jowc.2024.0071
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service